Oxidative Stress, Glutamate, and Neurodegenerative Disorders
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
There is an increasing amount of experimental evidence that oxidative stress is a causal, or at least an ancillary, factor in the neuropathology of several adult neurodegenerative disorders, as well as in stroke, trauma, and seizures. At the same time, excessive or persistent activation of glutamate-gated ion channels may cause neuronal degeneration in these same conditions. Glutamate and related acidic amino acids are thought to be the major excitatory neurotransmitters in brain and may be utilized by 40 percent of the synapses. Thus, two broad mechanisms—oxidative stress and excessive activation of glutamate receptors—are converging and represent sequential as well as interacting processes that provide a final common pathway for cell vulnerability in the brain. The broad distribution in brain of the processes regulating oxidative stress and mediating glutamatergic neurotransmission may explain the wide range of disorders in which both have been implicated. Yet differential expression of components of the processes in particular neuronal systems may account for selective neurodegeneration in certain disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and inflammation are early events of neurodegenerative diseases [920,944-957]”
In the citing paper
“lipid peroxidation could be a major feature of ferroptosis in AD”
In the citing paper
“the brain contains the high levels of polyunsaturated fatty acids (PUFAs) in its membrane rich architecture”
In the citing paper
“The pathophysiology of depression is multifactorial and includes changes in brain monoaminergic transmission (e.g., 5-HT, NE, DA), abnormalities in neurotransmitter receptors function (e.g., AC-cAMP pathway), reduced neurotrophic factors (e.g., BDNF), dysregulation of HPA axis (cortisol), increased proinflammatory cytokines (e.g., IL-6, TNF-α, NF-κB), increased NO (e.g., L-arginine-NO-cGMP pathway”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [45]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Glutamate: A Neurotransmitter in Mammalian Brain
Fonnum, F. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09689.x · Cited by 1,992
Research works printed but not linked: 8
- CHAN, P.H., REDUCED NEUROTOXICITY IN TRANSGENIC MICE OVEREXPRESSING HUMAN COPPER-ZINC SUPEROXIDE-DISMUTASE, STROKE 21: 80 (1990).
- CHOI, D.W., METHODS FOR ANTAGONIZING GLUTAMATE NEUROTOXICITY, CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 2: 105 (1990).
- DICHTER, M, EPILEPSIA 30: S3 (1989).
- HALLIWELL, B, ACTA NEUROLOGICA SCANDINAVICA 80 126: 23 (1989).
- JENNER, P, OXIDATIVE STRESS AS A CAUSE OF PARKINSONS-DISEASE, ACTA NEUROLOGICA SCANDINAVICA 84: 6 (1991).
- Olney, J. W., Kainic Acid as a Tool in Neurobiology: 95 (1978).
- SIESJO, B. K., CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 1: 165 (1989).
- TELLEZ-NAGEL, I, ADVANCES IN NEUROLOGY 1: 387 (1973).
Cited by
Items 901–1,000 of 1,019
Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review
Carrera‐Juliá, S., Moreno, M. L., Barrios, C., Ortí, J. E. D. L. R., & Drehmer, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00063 · Cited by 93
Huang, B., Tang, T., Chen, S., Li, H., Sun, Z., Zhang, Z., Zhang, M., & Cui, R. (2023) · Nature Communications · doi:10.1038/s41467-023-35868-8 · Cited by 89
Dictyoquinazols A, B, and C, New Neuroprotective Compounds from the Mushroom Dictyophora indusiata
Lee, I.-K., Yun, B.-S., Han, G., Cho, D., Kim, Y. H., & Yoo, I. (2002) · Journal of Natural Products · doi:10.1021/np020163w · Cited by 88
Liang, H., Ran, Q., Jang, Y. C., Holstein, D. M., Lechleiter, J. D., McDonald-Marsh, T., Musatov, A., Song, W. J., Remmen, H. V., & Richardson, A. G. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.012 · Cited by 88
“In addition, other apoptotic stimuli, such as TNF-α [6], ceramide [7], glutamate [8], amyloid-β-peptide [9], alkaline conditions [10], and nerve growth factor withdrawal [11], elevate intracellular ROS levels.”
BackgroundA rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue
Springer, J. E., Azbill, R. D., & Carlson, S. L. (1998) · Brain Research Protocols · doi:10.1016/s1385-299x(97)00045-7 · Cited by 88
Pyruvate and lactate protect striatal neurons against N‐methyl‐d‐aspartate‐induced neurotoxicity
Maus, M., Marin, P., Israël, M., Glowinski, J., & Prémont, J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00745.x · Cited by 88
“…triggered by glutamate seems to result from a sustained activation of the ionotropic N-Methyl-D-aspartate (NMDA) and/or aamino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/kainate glutamatergic receptor subtypes (Benveniste et al., 1984; Rothman & Olney, 1986; Coyle & Puttfarcken, 1993).”
BackgroundEffects of ischemia and H2O2 on the cold stress protein CIRP expression in rat neuronal cells
Xue, J.-H., Nonoguchi, K., Fukumoto, M., Sato, T., Nishiyama, H., Higashitsuji, H., Itoh, K., & Fujita, J. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00158-6 · Cited by 88
Enhanced hippocampal F2‐isoprostane formation following kainate‐induced seizures
Patel, M., Liang, L., & Roberts, L. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00659.x · Cited by 88
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
Schifitto, G., Zhang, J., Evans, S. R., Sacktor, N. C., Simpson, D. M., Millar, L., Hung, V., Miller, E. N., Smith, E. V., Ellis, R. J., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000268487.78753.0f · Cited by 92
Stimulation of N-methyl-?-aspartate receptors induces apoptosis in rat brain
Qin, Z., Wang, Y., & Chase, T. N. (1996) · Brain Research · doi:10.1016/0006-8993(96)00200-4 · Cited by 88
Yamamoto, Y., Mizuno, R., Nishimura, T., Ogawa, Y., Yoshikawa, H., Fujimura, H., Adachi, E., Kishimoto, T., Yanagihara, T., & Sakoda, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31756-3 · Cited by 85
Regulation of the human ether-a-gogo related gene (HERG) K + channels by reactive oxygen species
Taglialatela, M., Castaldo, P., Iossa, S., Pannaccione, A., Fresi, A., Ficker, E. K., & Annunziato, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11698 · Cited by 88
Arachidonic acid: Toxic and trophic effects on cultured hippocampal neurons
Okuda, S., Saitō, H., & Katsuki, H. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90515-0 · Cited by 88
Lovell, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0992 · Cited by 87
“…etiologic/pathogenic mechanisms have been suggested for the cause of AD including genetic defects [10,30], the amyloid cascade hypothesis (reviewed in [31]), trace element toxicity (reviewed in [32]), the oxidative stress hypothesis [33], mitochondrial defects [34], or a combination of the above.”
Disruptive effects of glucocorticoids on glutathione peroxidase biochemistry in hippocampal cultures
Patel, R., McIntosh, L., McLaughlin, J., Brooke, S., Nimon, V., & Sapolsky, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00948.x · Cited by 85
“ROS are important to neuronal function at many levels, from simple modulation of the function of various receptors to degradation of mitochondrial function and triggering of complex cell-death pathways (Coyle and Puttfarcken 1993).”
BackgroundNMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease
Huang, Y.-J., Lin, C.-H., Lane, H.-Y., & E. Tsaid, G. (2012) · Current Neuropharmacology · doi:10.2174/157015912803217288 · Cited by 85
“Augmentation through the NMDAR-glycine binding site is preferred to avoid the excitotoxicity mediated through the glutamate binding site [106].”
Fernandez, A. M., Jiménez, S., Mecha, M., Dávila, D., Guaza, C., Vitórica, J., & Torres‐Alemán, I. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.128 · Cited by 93
Echinacoside rescues the SHSY5Y neuronal cells from TNFα-induced apoptosis
Deng, M., Zhao, J. Y., Tu, P., Jiang, Y., Li, Z. B., & Wang, Y. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.059 · Cited by 87
Iwashita, A., Tojo, N., Matsuura, S., Yamazaki, S., Kamijo, K., Ishida, J., Yamamoto, H., Hattori, K., Matsuoka, N., & Mutoh, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066944 · Cited by 96
Cathepsin D–Bax death pathway in oxidative stressed neuroblastoma cells
Castino, R., Bellio, N., Nicotra, G., Follo, C., Trincheri, N. F., & Isidoro, C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.030 · Cited by 86
Sharp, C. D., Houghton, J., Elrod, J. W., Warren, A., Jackson, T. H., Jawahar, A., Nanda, A., Minagar, A., & Alexander, J. S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01110.2003 · Cited by 81
“After the IHEC were loaded with DHR, the cells were exposed to 1 mM glutamate [concentrations of 1–10 mM glutamate are commonly used to model stroke or excitotoxic events (11, 12, 17, 47)], and the change in fluorescent intensity was read with a fluorometer over time (for 30 min at 37°C).”
Recent Updates in Neuroprotective and Neuroregenerative Potential of Centella asiatica.
Lokanathan, Y., Omar, N., Puzi, N. N. A., Saim, A. B., & Idrus, R. B. H. (2016) · Europe PMC (PubMed Central) · Cited by 122
Behl, C. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070082 · Cited by 87
“Since brain cells are at a particular risk of damage caused by oxidations, oxidative stress has been linked to the pathogenesis of various neurodegenerative disorders including Alzheimer’s disease (AD) (for review: Fridovich, 1978; Ames et al., 1993; Coyle and Puttfarcken, 1993; Beal, 1995).”
BackgroundInfluentialPall, M. L. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1325 · Cited by 95
Phillips, R. G., Meier, T. J., Giuli, L. C., McLaughlin, J. R., Ho, D. Y., & Spolsky, R. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731200.x · Cited by 87
Coenzyme Q and Its Role in the Dietary Therapy against Aging
Varela-López, A., Giampieri, F., Battino, M., & Quiles, J. (2016) · Molecules · doi:10.3390/molecules21030373 · Cited by 86
“In addition, a negative correlation has been reported between CoQ levels and the duration of illness in Amyotrophic Lateral Sclerosis [145], Alzheimer’s [146] and Parkinson’s disease case studies [147].”
BackgroundKim, D. H., Kim, D. W., Jung, B. H., Lee, J. H., Lee, H., Hwang, G. S., Kang, K. S., & Lee, J. W. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.12.002 · Cited by 86
Kumar, M. V., & Gupta, Y. K. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00838-9 · Cited by 86
Tan, Y. L., Zhou, D. F., & Zhang, X. Y. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.004 · Cited by 87
“There are a number of possible mechanisms for neuronal degeneration in TD, including free radical (Lohr, 1991; Lohr and Browning, 1995) and excitotoxicity mechanisms (Coyle and Puttfarcken, 1993).”
BackgroundMukherjee, P. K., Ahamed, K. N., Venkatesan, K., Mukherjee, P. K., & Houghton, P. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.12.025 · Cited by 86
Shao, L., Sun, X., Xu, L., Young, L. T., & Wang, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.007 · Cited by 99
“Glutamate induced toxicity is known to be a consequence of induced supraphysiologically prolonged activation of glutamate receptors, resulting in imbalance of neuronal Ca homeostasis, mitochondrial depolarization, respiratory inhibition and production of reactive oxygen species (Coyle and Puttfarcken, 1993; Leist and…”
BackgroundOxidative stress and Alzheimer's disease
Choi, B. H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00065-m · Cited by 86
Cotter, R. L., Burke, W. J., Thomas, V. S., Potter, J. F., Zheng, J., & Gendelman, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.416 · Cited by 86
“via direct or indirect mechanisms [85].”
Noack, H., Lindenau, J., Rothe, F., Asayama, K., & Wolf, G. (1998) · Glia · doi:10.1002/(sici)1098-1136(199808)23:4<285::aid-glia1>3.0.co;2-2 · Cited by 90
Free radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 89
Zhang, J., Li, X., Shen, L., Khan, N. U., Zhang, X., Chen, L., Zhao, H., & Luo, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126782 · Cited by 87
Neuroglobin protects PC12 cells against β-amyloid-induced cell injury
Li, R. C., Pouranfar, F., Lee, S. K., Morris, M. W., Wang, Y., & Gozal, D. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.001 · Cited by 89
“Several studies suggest that the oxidative stress play a key role in Aβ-mediated neuronal cytotoxicity by triggering or facilitating neurodegeneration through a wide range of molecular events which eventually lead to neuronal cell loss (Barkats et al., 2000; Coyle and Puttfarcken, 1993; Crack et al., 2006; Huang et al…”
BackgroundInfluentialKoh, S., Kim, S. H., Kwon, H., Kim, J. G., Kim, J. H., Yang, K.-H., Kim, J., Kim, S. U., Yu, H., Rok, B., et al. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.02.001 · Cited by 85
The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets
Xu, W., Gao, L., Zheng, J., Li, T., Shao, A., Reis, C., Chen, S., & Zhang, J. (2018) · Cell Transplantation · doi:10.1177/0963689718773361 · Cited by 85
Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation
Levi, S., Cozzi, A., & Arosio, P. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.021 · Cited by 91
Free radicals and neurodegeneration
Cadet, J. L. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90102-3 · Cited by 85
Deferoxamine improves spatial memory performance following experimental brain injury in rats
Long, D. A., Ghosh, K., Moore, A. N., Dixon, C. E., & Dash, P. K. (1996) · Brain Research · doi:10.1016/0006-8993(95)01500-0 · Cited by 85
Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist
Eshhar, N., Striem, S., Kohen, R., Tirosh, O., & Biegon, A. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00271-l · Cited by 88
Sinor, J. D., Du, S., Venneti, S., Blitzblau, R. C., Leszkiewicz, D. N., Rosenberg, P. A., & Aizenman, E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08831.2000 · Cited by 85
“We currently favor the hypothesis that glutamate toxicity in mature astrocyte-rich cortical cultures requires not only NMDA receptor activation, but also at least a second injurious process, such as oxidative stress (Coyle and Puttfarcken, 1993).”
BackgroundResveratrol modulates astroglial functions: neuroprotective hypothesis
Quincozes‐Santos, A., & Gottfried, C. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05857.x · Cited by 93
Brimson, J. M., Brimson, S. J., Brimson, C. A., Rakkhitawatthana, V., & Tencomnao, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13045074 · Cited by 83
“Accumulation of reactive oxygen species (ROS) in the cell, resulting from an imbalance of enzymatic and non-enzymatic oxygen free radical production or destruction, leads to lipid peroxidation, protein oxidation, and DNA damage, which in turn can lead to cell death [4–8].”
BackgroundAcetyl-l-Carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats
Barhwal, K. K., Singh, S. B., Hota, S. K., Jayalakshmi, K., & Ilavazhagan, G. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.063 · Cited by 84
Janani, S., Stevenson, P., Subramaniam, S., Raghavan, R., Pemaiah, B., Sivasubramanian, A., & Veerappan, A. (2013) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2013.08.114 · Cited by 84
Aliev, G., Smith, M. A., de la Torre, J. C., & Perry, G. L. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.018 · Cited by 87
Crespo‐Biel, N., Canudas, A. M., Camins, A., & Pallàs, M. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.10.002 · Cited by 89
Zhang, Y., & Bhavnani, B. R. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-13 · Cited by 84
“The mechanisms by which glutamate-induced neurotoxicity or excitotoxicity is mediated, has not been established, however, a substantial body of evidence suggests that glutamate toxicity involves oxidative stress and apoptosis (programmed cell death) [2,7-9].”
BackgroundFontaine, M. A. L., Geddes, J. W., Banks, A., & Butterfield, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01948-x · Cited by 84
Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures
Strasser, U., Lobner, D., Behrens, M. M., Canzoniero, L. M. T., & Choi, D. W. (1998) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1998.00291.x · Cited by 84
Chemical composition, antioxidant and anticholinesterase activity of Melissa officinalis
Pereira, R. P., Boligon, A. A., Appel, A. S., Fachinetto, R., Ceron, C. S., Tanus-Santos, J. E., Athayde, M. L., & da Rocha, J. B. T. (2014) · Industrial Crops and Products · doi:10.1016/j.indcrop.2013.12.007 · Cited by 94
Bioactive Polyphenols from Healthy Diets and Forest Biomass
Stevanović, T., Diouf, P. N., & García‐Pérez, M. (2009) · Current Nutrition & Food Science · doi:10.2174/157340109790218067 · Cited by 92
Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative
Prókai-Tátrai, K., Perjési, P., Rivera‐Portalatin, N. M., Simpkins, J. W., & Prókai, L. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.011 · Cited by 86
The Role of Reactive Oxygen Species (ROS) in Persistent Pain
Chung, J. M. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.3 · Cited by 83
Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia
McGowan, J. E., Chen, L., Gao, D., Trush, M. A., & Wei, C. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.034 · Cited by 90
Choi, H., Park, H., Koh, S., Choi, N.-Y., Yu, H., Park, J., Lee, Y. J., & Lee, K. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.12.005 · Cited by 86
Lv, C., Xing, Y., Zeng, H., Liu, R., & Zhang, W. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.009 · Cited by 83
“Evidence is accumulating that elevated levels of extracellular glutamate can damage neurons, have been postulated to mediate central nervous system (CNS) damage from conditions such as hyperglycemia, ischemia, hypoxia (Choi, 1988), and may be involved in CNS disorders such as Huntington's, Alzheimer's, and Parkinson's…”
BackgroundLindenau, J., Noack, H., Asayama, K., & Wolf, G. (1998) · Glia · doi:10.1002/(sici)1098-1136(199810)24:2<252::aid-glia10>3.0.co;2-z · Cited by 82
Neurotoxicity of Endogenous Cysteinylcatechols
Montine, T. J., Picklo, M. J., Amarnath, K., Whetsell, W. O., & Graham, D. G. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6662 · Cited by 83
DNA alkylation repair limits spontaneous base substitution mutations in Escherichia coli
Mackay, W. J., Han, S., & Samson, L. D. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.11.3224-3230.1994 · Cited by 84
“Some normal intermediary metabolites and some by-products of normal metabolism are cytotoxic compounds that can attack nucleic acids, proteins, and lipids (2, 12, 29, 36).”
Quincozes‐Santos, A., Bobermin, L. D., Tramontina, A. C., Wartchow, K. M., Tagliari, B., Souza, D. O., Wyse, Â. T. D. S., & Gonçalves, C. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.12.021 · Cited by 88
“Glutamate exposure and/or NMDA activation induces impaired mitochondrial function, increased intracellular Ca overload, peroxynitrite generation and neuronal death, which are characteristic of neurological disorders (Bolanos and Heales, 2010; Coyle and Puttfarcken, 1993).”
BackgroundInfluentialArany, I., Faisal, A., Nagamine, Y., & Safirstein, R. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708799200 · Cited by 82
Possible roles of excess tryptophan metabolites in cancer
Chung, K., & Gadupudi, G. S. (2011) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20588 · Cited by 78
“Most of these diseases are associated with neuronal cell death caused by oxidative stress [Coyle and Puttfarcken, 1993].”
BackgroundOikawa, S., Yamada, T., Minohata, T., Kobayashi, H., Furukawa, A., Tada‐Oikawa, S., Hiraku, Y., Murata, M., Kikuchi, M., & Yamashima, T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.029 · Cited by 88
Mao, Q., Zhong, X., Feng, C.-R., Pan, A.-J., Li, Z., & Huang, Z. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9537-5 · Cited by 82
“However, in a variety of pathologic conditions, high concentration accumulation of glutamate can lead to neuronal injury or even death in the hippocampus (Coyle and Puttfarcken 1993; Lipton and Rosenberg 1994; Wang et al. 2008), which is thought to play an important role in the pathogenesis of depression (Magariños et…”
BackgroundAtroshi, F., Biese, I., Saloniemi, H. S., Ali-Vehmas, T., Saari, S., Rizzo, A. F., & Veijalainen, P. (2000) · PubMed · Cited by 99
Wang, H., Cheng, E., Brooke, S., Chang, P., & Sapolsky, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02123.x · Cited by 79
Amygdalo‐Entorhinal Inputs to the Hippocampal Formation in Relation to Schizophrenia
BENES, F. M., & BERRETTA, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06733.x · Cited by 80
Payá, M., Goodwin, P. A., Heras, B. D. L., & Hoult, J. R. S. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90273-9 · Cited by 82
Larm, J. A., Beart, P. M., & Cheung, N. S. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(97)00030-2 · Cited by 89
Ueda, Y., Yokoyama, H., Ryuji, N. I. W. A., Konaka, R., Ohya‐Nishiguchi, H., & Kamada, H. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(96)00901-1 · Cited by 87
Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
Gilbert, G. L., Kim, H. J., Waataja, J. J., & Thayer, S. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.011 · Cited by 94
TRPs as Chemosensors (ROS, RNS, RCS, Gasotransmitters)
Shimizu, S., Takahashi, N., & Mori, Y. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-05161-1_3 · Cited by 83
DNA Fragmentation Decreased in Schizophrenia but Not Bipolar Disorder
Benes, F. M., Walsh, J., Bhattacharyya, S., Sheth, A., & Berretta, S. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.359 · Cited by 82
Dhir, A., Naidu, P. S., & Kulkarni, S. K. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.003 · Cited by 84
Ganglioside GM3 is involved in neuronal cell death
Sohn, H., Kim, Y.-S., Kim, H.-T., Kim, C., Cho, E., Kang, H., Kim, N.-S., Kim, C., Ryu, S. E., Lee, J. H., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4911fje · Cited by 87
“tion of ionotropic glutamate receptors (3, 4), oxidative”
BackgroundCunningham, T. J., Hodge, L. M., Speicher, D. J., Reim, D. F., TYLER-POLSZ, C. J., Levitt, P. R., Eagleson, K. L., Kennedy, S., & Wang, Y. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07047.1998 · Cited by 81
“For example, neuron death or rescue resulting from trauma, altered neurotransmitter levels, b-amyloid toxicity, neurohormone treatment, and neurotrophic factor treatment or deprivation all can be related to the production or sequestering of reactive oxygen species (for review, see Coyle and Puttfarcken, 1993; Mattson…”
BackgroundGloor, S. M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00774-6 · Cited by 81
Wang, X., Chen, S., Ma, G., Ye, M., & Lü, G. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.06.012 · Cited by 83
Ferger, B., Spratt, C., Earl, C. D., Teismann, P., Oertel, W. H., & Kuschinsky, K. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005264 · Cited by 84
Skaper, S. D., Ancona, B., Facci, L., Franceschini, D., & Giusti, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.9.725 · Cited by 85
“Several lines of evidence suggest that reactive oxygen species (ROS) play a pivotal role in the pathogenesis of excitotoxic death (10).”
BackgroundGalantamine-Memantine combination in the treatment of Alzheimer's disease and beyond
Koola, M. M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113409 · Cited by 85
Update on Antioxidant Therapy with Edaravone: Expanding Applications in Neurodegenerative Diseases
Yamashita, T., & Abe, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052945 · Cited by 85
“Briefly, oxidative stress is caused by an imbalance between the production and accumulation of reactive oxygen species (ROS) in cells and tissues and the ability of a biological system to detoxify these reactive products [1].”
BackgroundMao, X., Zhou, H., Li, X., & Liu, Z. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0276-5 · Cited by 82
“Cells were observed under a laser-scanning confocal microscope (Nikon, Japan) with an excitation wavelength of 490 nm and an emission wavelength of 525 nm. Fluorescence intensity was calculated using a Multilabel counter (Perkin-Elmer 1420, MA, USA).”
BackgroundMethodEbselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain
Bürger, M. E., Fachinetto, R., Zeni, G. R., & da Rocha, J. B. T. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.05.002 · Cited by 80
Brain oxidation is an initial process in sleep induction
Ikeda, M., Ikeda‐Sagara, M., Okada, T., Clément, P., Urade, Y., Nagai, T., Sugiyama, T., Yoshioka, T., Honda, K., & Inoue, S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.057 · Cited by 89
Rebec, G. V., Barton, S. J., & Ennis, M. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-j0006.2002 · Cited by 81
“A low level of striatal ascorbate is consistent with inadequate antioxidant protection as a basis for HD pathogenesis (Coyle and Puttfarcken, 1993).”
BackgroundWEINSTOCK, M., KIRSCHBAUM‐SLAGER, N., LAZAROVICI, P., BEJAR, C., YOUDIM, M. B. H., & SHOHAM, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03622.x · Cited by 81
Lack of glutathione peroxidase-1 exacerbates Aβ-mediated neurotoxicity in cortical neurons
Crack, P. J., Cimdins, K., Ali, U., Hertzog, P. J., & Iannello, R. C. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0352-y · Cited by 83
“Intracellular accumulation of H2O2 is equally dangerous to the cell, given that catalytic levels of transition metals such as Fe2þ or Cuþ (Coyle and Puttfarcken, 1993) can convert it to hydroxyl radicals.”
BackgroundFroissard, P., Monrocq, H., & Duval, D. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00155-6 · Cited by 80
Kondo, T., Sharp, F. R., Honkaniemi, J., Mikawa, S., Epstein, C. J., & Chan, P. H. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199703000-00001 · Cited by 80
“Oxygen radicals and lipid peroxida tion have also been suggested to be mediators of KA neurotoxicity (Dykens et aI., 1987; Miyamoto and Coyle, 1990; Sun et aI., 1992; Coyle and Puttfarcken, 1993), as has arachidonic acid metabolism, because an inhibitor of cyclo-oxygenase and lip oxygenase (BW755C) protects animals a…”
BackgroundExcitotoxic neuronal damage and neuropsychiatric disorders
Zorumski, C. F., & Olney, J. W. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90043-d · Cited by 84
Adenosine, antioxidant enzymes and cytoprotection
Ramkumar, V., Nie, Z., Rybak, L. P., & Maggirwar, S. B. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89051-3 · Cited by 83
Benes, F. M., Todtenkopf, M. S., & Kostoulakos, P. (2001) · Hippocampus · doi:10.1002/hipo.1065 · Cited by 79
“In this setting, collateral branches of PNs would provide a secondary increase of excitatory input to GABAergic cells and, if intense and/or prolonged enough, could result in variable degrees of neuronal pathology (Coyle and Puttfarcken, 1993).”
Oxidative stress in Rett syndrome
Sierra, C., Vilaseca, M. A., Brandi, N., Artuch, R., Mira, A., Nieto, M., & Pineda, M. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00369-2 · Cited by 79
Isolated preparations of ocular vasculature and their applications in ophthalmic research
Yu, D., Su, E.-N., Cringle, S. J., & Yu, P. K. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00044-7 · Cited by 84
Toward understanding genomic instability, mitochondrial dysfunction and aging
Fakouri, N. B., Hou, Y., Demarest, T. G., Christiansen, L. S., Okur, M. N., Mohanty, J. G., Croteau, D. L., & Bohr, V. A. (2019) · The FEBS Journal · doi:10.1111/febs.14663 · Cited by 77
Metadata
- Authors
- Coyle, J. T., & Puttfarcken, P.
- Affiliations
- Harvard University (US)
- ORCID
- Coyle, Joseph T.
- Venue
- Science
- Published
- 1993-10-29
- Volume
- 262
- Issue
- 5134
- Pages
- 689-695
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2016293448
- Cited by
- 3,762
- References
- 104
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 56 · 2023: 58 · 2022: 51 · 2021: 66 · 2020: 74 · 2019: 83 · 2018: 89 · 2017: 104 · 2016: 105 · 2015: 99 · 2014: 158 · 2013: 126 · 2012: 137
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, glutamate, neurodegenerative diseases, glutamate receptors, excitotoxicity, glutamatergic neurotransmission, neurodegeneration, stroke, traumatic brain injury, seizures, selective neurodegeneration, acidic amino acids
- MeSH terms
- Animals, Brain, Glutamates, Humans, Nervous System Diseases, Reactive Oxygen Species, Receptors, Glutamate, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.